Elevian, Inc.

As venture capital financings for biopharmaceutical companies continues to head into record-breaking territory again in 2021, Illumina Ventures and Jeito Capital announced two new venture capital fund

Four new sources of venture capital for biotechnology companies were announced during the first half of May with more than $1.7bn in fresh funding for start-ups and growing early-stage firms. Abingwor

Biopharmaceutical venture capital fundraising has not slowed its record-breaking pace during the holiday season and the VC boom has extended to life science tools and services, including two recent me